๐๏ธ Verified NIH Record โข Updated 2026-08-20
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors (NCT05797168)
๐ข Recruiting Phase1 / Phase2 ๐ Investigational Drug / Biologic Sponsor: AstraZeneca
๐ฉบ Plain-English Summary (8th-Grade Level)
This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer agents is safe, tolerable, and has anti-cancer activity in patients with advanced tumors
Who can join: Review the eligibility criteria below.
Location: Research Site โ Duarte, California
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (60 Sites)
- Research Site โ Duarte, California
- Research Site โ Irvine, California
- Research Site โ La Jolla, California
- Research Site โ Aurora, Colorado
- Research Site โ Louisville, Kentucky
- Research Site โ Boston, Massachusetts
- Research Site โ Detroit, Michigan
- Research Site โ Columbus, Ohio
- Research Site โ Portland, Oregon
- Research Site โ Providence, Rhode Island
- Research Site โ Providence, Rhode Island
- Research Site โ Houston, Texas
- Research Site โ Fairfax, Virginia
- Research Site โ Liverpool,
- Research Site โ Melbourne,
- Research Site โ Edmonton, Alberta
- Research Site โ London, Ontario
- Research Site โ Toronto, Ontario
- Research Site โ Montreal, Quebec
- Research Site โ Montreal, Quebec
- Research Site โ Chengdu,
- Research Site โ Chongqing,
- Research Site โ Guangzhou,
- Research Site โ Guangzhou,
- Research Site โ Jinan,
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.